Table 1 Demographic and clinical characteristics of IgAV patients, IgAVN, sl-IgAV and HC included in RNA sequencing
From: Exhausted natural killer cells in adult IgA vasculitis
Characteristics | IgAV (n = 6) | IgAVN (n = 3) | sl-IgAV (n = 3) | HC (n = 3) |
|---|---|---|---|---|
Age* | 66.5 (56.6–76.7) | 66.6 (66.3–74.2) | 64.0 (34.2–84.2) | 53.0 (48.0–57.5) |
Sex | 1 M, 5 F | 3 F | 1 M, 2 F | 3 F |
BMI* | 30.4 (24.6–35.9) | 31.8 (26.0–40.0) | 29.1 (20.4–34.5) | / |
Symptom duration (day)* | 5.5 (3.5–38) | 5 (2–14) | 6 (4–110) | / |
Skin purpura | 6 | 3 | 3 | / |
Daily proteinuria (g/day)* | 0.351 (0.069–0.793) | 0.474 (0.076–1.09) | 0.228 (0.048–0.693) | / |
Hematuria | 3 microhematuria | 3 microhematuria | 0 | / |
CRP (g/l)* | 51.5 (27.8–135.8) | 58 (32–198) | 45 (15–115) | / |
SAA (µg/ml) | 38.4 (0–175) | 302 (92.5–933) | 38.4 (0.00–598.0) | / |
Number of lymphocytes (109/l)* | 1.83 (1.08–2.62) | 1.58 (0.75–2.57) | 2.08 (1.19–2.76) | / |
Number of neutrophils (109/l)* | 5.12 (4.12–6.19) | 4.5 (4.47–6.94) | 7.46 (4.31–10.44) | / |
BVAS* | 7 (2–11) | 8 (8–20) | 2 (2–6) | / |
Concurrent infection | 1 | 0 | 1 | / |
Prior infection | 2 | 1 | 1 | / |